The estimated Net Worth of Lynne Marie Sullivan is at least $551 Thousand dollars as of 2 August 2024. Ms Sullivan owns over 139 units of Unity Biotechnology Inc stock worth over $78,485 and over the last 6 years she sold UBX stock worth over $666. In addition, she makes $471,364 as CFO & Head of Corp. Devel. at Unity Biotechnology Inc.
Sign up
Ms Sullivan UBX stock SEC Form 4 insiders trading
Ms has made over 3 trades of the Unity Biotechnology Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 139 units of UBX stock worth $213 on 2 August 2024.
The largest trade she's ever made was buying 12,500 units of Unity Biotechnology Inc stock on 28 July 2021 worth over $50,000. On average, Ms trades about 447 units every 38 days since 2018. As of 2 August 2024 she still owns at least 56,061 units of Unity Biotechnology Inc stock.
You can see the complete history of Ms Sullivan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Lynne Marie Sullivan biography
Lynne Marie Sullivan is the CFO & Head of Corp. Devel. at Unity Biotechnology Inc.
What is the salary of Ms Sullivan?
As the CFO & Head of Corp. Devel. of Unity Biotechnology Inc, the total compensation of Ms Sullivan at Unity Biotechnology Inc is $471,364. There are 6 executives at Unity Biotechnology Inc getting paid more, with Keith Leonard having the highest compensation of $3,270,820.
How old is Ms Sullivan?
Ms Sullivan is 55, she's been the CFO & Head of Corp. Devel. of Unity Biotechnology Inc since . There are 9 older and 12 younger executives at Unity Biotechnology Inc. The oldest executive at Unity Biotechnology Inc is David Lacey, 67, who is the Independent Director.
What's Ms Sullivan's mailing address?
Lynne's mailing address filed with the SEC is 285 EAST GRAND AVE, , SOUTH SAN FRANCISCO, CA, 94080.
Insiders trading at Unity Biotechnology Inc
Over the last 7 years, insiders at Unity Biotechnology Inc have traded over $9,012,473 worth of Unity Biotechnology Inc stock and bought 3,200 units worth $28,480 . The most active insiders traders include Kristina Burow, Robert Nelsen, and Nathaniel E David. On average, Unity Biotechnology Inc executives and independent directors trade stock every 54 days with the average trade being worth of $65,316. The most recent stock trade was executed by Alexander Hieu Nguyen on 2 August 2024, trading 154 units of UBX stock currently worth $236.
What does Unity Biotechnology Inc do?
unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at www.unitybiotechnology.com.
What does Unity Biotechnology Inc's logo look like?
Complete history of Ms Sullivan stock trades at Solid Biosciences Inc, resTORbio, Unity Biotechnology Inc, BiomX Inc, and Inozyme Pharma
Unity Biotechnology Inc executives and stock owners
Unity Biotechnology Inc executives and other stock owners filed with the SEC include:
-
Keith Leonard,
Chairman of the Board -
Margo Roberts,
Independent Director -
Nathaniel David,
President, Co-Founder, Director -
Dr. Anirvan Ghosh,
CEO & Director -
Dr. Jamie Dananberg M.D.,
Chief Medical Officer -
Dr. Jamie Dananberg,
Chief Medical Officer -
Lynne Marie Sullivan,
CFO & Head of Corp. Devel. -
Paul Berns,
Independent Director -
Graham Cooper,
Independent Director -
David Lacey,
Independent Director -
Kristina Burow,
Independent Director -
Camille Samuels,
Independent Director -
Robert Nelsen,
Director -
Dr. Nathaniel E. David A.B., Ph.D.,
Co-Founder & Exec. Director -
Luis Visoso,
Director -
Mary Campbell,
Director -
Jamie Dananberg,
Chief Medical Officer -
Tamara Tompkins,
General Counsel and Corporate Secretary -
Dan Marquess,
Chief Scientific Officer -
Lynne Sullivan,
Chief Financial Officer, Chief Accounting Officer -
Anirvan Ghosh,
Chief Executive Officer, Director -
Dr. Nathaniel E. David,
Co-Founder & Exec. Director -
Susan Lundeen Smuck,
Chief HR Officer -
Dr. Przemyslaw Sapieha Ph.D.,
Chief Scientific Advisor -
Alexander Azoy,
VP of Fin., Chief Accounting Officer, Controller & Principal Accounting Officer -
Nathan Guz Ph.D.,
VP of Operations -
Daohong Zhou M.D.,
Founder -
Dr. Judith Campisi,
Founder -
Dr. Jan M. van Deursen,
Founder -
Alexander Azoy,
See Remarks -
Alexander Hieu Nguyen,
Chief Legal Officer -
Ii Robert C. Goeltz,
Chief Financial Officer -
Venture Partners Vii, Llcar...,
-
Michael P. Samar,
-
Gilmore Neil O'neill,